Latest News

• share
• favorite_border

Prolonged delays in breast cancer screening related to the COVID-19 pandemic have led to delayed diagnosis, poor health outcomes, and an increase in disparities. To address this, Mount Sinai Health System has launched “Mammogram May” to empower women to take charge of their breast health by scheduling an annual mammogram.

• share
• favorite_border

An advanced radiotherapy technique called radiation segmentectomy may be effective against very early to early-stage hepatocellular carcinoma (HCC), a type of liver cancer that cannot be treated surgically or thermally.

• share
• favorite_border

The National Institutes of the Health (NIH) has awarded researchers at the Icahn School of Medicine at Mount Sinai a four-year grant to study the role of the human microbiome in rheumatoid arthritis, systemic lupus, and other autoimmune diseases. The grant is part of the NIH’s Accelerating Medicines Partnership® Autoimmune and Immune-Mediated Diseases (AMP® AIM) program, which is designed to speed the discovery of new treatments and diagnostics. It will support the Microbiome Technology and Analytic Center Hub (Micro-TEACH), a multidisciplinary team of researchers at Icahn Mount Sinai and NYU Langone Health.

• share
• favorite_border

Mount Sinai Health System has appointed Bruce D. Gelb, MD, as Dean for Child Health Research at the Icahn School of Medicine at Mount Sinai.

• share
• favorite_border

The Mount Sinai Hospital has earned top honors on Newsweek’s list of “America’s Best Maternity Hospitals 2022” for providing high-quality maternity care from pregnancy through birth, as well as postpartum care to ensure the long-term health of both newborns and new mothers.

• share
• favorite_border

Marking a major advance in its efforts to achieve equity in the delivery of health care, the Icahn School of Medicine at Mount Sinai (Icahn Mount Sinai) announced today that its Institute for Health Equity Research (IHER) has received a landmark $20 million gift over five years from Royalty Pharma plc (Nasdaq: RPRX) and certain members of its management team.

• share
• favorite_border

Immunotherapy after surgery helped reduce cancer recurrence in patients with urothelial cancer of the bladder or other sites in the urinary tract that had invaded the muscle and therefore posed a high risk for recurrence, according to clinical trial results presented at the American Urological Association (AUA) annual meeting in May.

• share
• favorite_border

Rensselaer Polytechnic Institute and the Icahn School of Medicine at Mount Sinai today announced the creation of the Center for Engineering and Precision Medicine (CEPM), one of the first centers in the nation to bridge engineering and engineering science with medicine. This undertaking will build on a wealth of shared basic research discoveries, explore unique therapeutic innovations in cancer, Alzheimer’s and a myriad of infectious diseases; educate a new generation of biomedical leaders; and develop new technologies and processes that enhance patient outcomes in unprecedented ways. CEPM represents an evolution in the successful partnership between Mount Sinai and RPI, one that has secured over $70 million in shared research funding since 2013 with 90 percent of that provided by the National Institutes of Health.

• share
• favorite_border

On May 11 at 3pm, the Icahn School of Medicine at Mount Sinai will grant 127 MD degrees and 43 PhD degrees to the graduating class of 2022 at Carnegie Hall in New York. With a turbulent and memorable medical school journey marked by the COVID-19 pandemic, this year’s class has been severely battle- tested. It is also distinguished as one of Icahn Mount Sinai’s most diverse. Admiral Rachel L. Levine, MD, the first openly transgender federal official to be confirmed by the U.S. Senate, will receive an honorary degree and will deliver the commencement address, while American artist and activist Faith Ringgold will receive an honorary degree.

• share
• favorite_border

The Mount Sinai Health System was ranked No. 5 in the nation on DiversityInc’s Top Hospitals and Health Systems list for 2022.

• share
• favorite_border

The cohort study follows women through pregnancy and birth to study if a SARS-CoV-2 infection, the virus that causes COVID-19, is associated with poor pregnancy outcomes.

• share
• favorite_border

Researchers share insights about the mechanisms of human embryo and create method to develop transcriptionally similar cells in tissue culture; latest discovery a step closer to finding alternative for bone marrow and other cancer treatments.

• share
• favorite_border

CarepathRx, a leader in health system pharmacy and medication management solutions, today announced a comprehensive home infusion pharmacy partnership with Mount Sinai Health System, New York City’s largest academic health system.

• share
• favorite_border

Mount Sinai researchers have discovered a previously unknown mechanism in which not-yet-malignant cells from early breast cancer tumors travel to other organs and, eventually, “turn on” and become metastatic breast cancer.

• share
• favorite_border

The Emergency Medicine Residents' Association (EMRA) of the American College of Emergency Physicians has honored Brendan G. Carr, MD, MS, Chair of Emergency Medicine at the Icahn School of Medicine of Mount Sinai and Mount Sinai Health System, with the prestigious “2022 Chair of the Year Award.” He is the only department chair in the country to receive this distinction for 2022, recognizing his exceptional leadership.

• share
• favorite_border

The Canopy Cancer Collective, a national nonprofit organization that strives to fuel better treatments and outcomes for pancreatic cancer patients, has awarded The Tisch Cancer Institute at Mount Sinai a $500,000 grant to support continued innovation in its multidisciplinary treatment of pancreatic cancer.

• share
• favorite_border

Mount Sinai Innovation Partners (MSIP), the commercialization arm of the Mount Sinai Health System in New York, New York, has launched i3 Prism, a technology commercialization fund focused on women and Black, Indigenous and people of color (BIPOC) health care innovators.

• share
• favorite_border

Mount Sinai Kravis Children’s Hospital will be the first children’s hospital in Manhattan to use a new, state-of-the art seizure monitoring device that facilitates rapid, point-of-care detection and diagnosis of non-convulsive seizure activity in critically ill children to ensure they receive optimal treatment as quickly as possible.

• share
• favorite_border

Mount Sinai Health System has received a top score of 100 and the designation of “LGBTQ+ Healthcare Equality Leader” in the Human Rights Campaign Foundation’s 15th anniversary edition of the Healthcare Equality Index (HEI).

• share
• favorite_border

New study outlines scalable protocol to enhance development and understanding of human pluripotent stem cells in cardiac muscles

• share
• favorite_border

Mutation of a gene called ARID2 plays a role in increasing the chance that melanoma, a deadly skin cancer, will turn dangerously metastatic, Mount Sinai researchers report.

• share
• favorite_border

Most immunocompromised people with a blood cancer called multiple myeloma benefited from a third dose of COVID-19 vaccines, a promising sign after it was shown that two doses tended to not be sufficient for them. However, some people with multiple myeloma still remained vulnerable and may need a fourth dose or antibody treatments as restrictions lift and new variants emerge, according to a fast-tracked study in Cancer Cell.

• share
• favorite_border

Clinical awareness of connection between alcohol and dementia is paramount to providing the best patient care management

• share
• favorite_border

Mount Sinai Heart leader will be recognized for his exceptional achievements at the 71st annual conference

• share
• favorite_border

Program employs a coordinated approach and serves as a template for response against rapidly evolving pandemic pathogens

• share
• favorite_border

On Friday, April 1 at 2p.m., the Milton and Caroll Petrie Department of Urology at Mount Sinai will host a ribbon cutting ceremony in Wagner Houses’ Community Plaza Ground, 451 East 120th Street, to celebrate the launch of the Mount Sinai Robert F. Smith Mobile Prostate Cancer Screening Unit.

• share
• favorite_border

Mount Sinai researchers have developed a novel method to identify aggressive early-stage lung cancers and target drugs known as aurora kinase inhibitors to tumors that are especially likely to respond to them.

• share
• favorite_border

The Mount Sinai Health System has announced a collaboration with PUSH for Empowered Pregnancy to establish the nation’s first multidisciplinary specialty clinic for women who have experienced stillbirth.

• share
• favorite_border

Mount Sinai Study finds that youth exposed to environmental tobacco smoke experienced significantly lower odds of wheezing when maintaining a higher quality diet

• share
• favorite_border

In an unparalleled effort to deliver outstanding comprehensive care and to employ revolutionary approaches to novel therapeutics around the skin condition alopecia areata, the Mount Sinai Health System has launched the Alopecia Areata Center of Excellence. Under the leadership of Director Emma Guttman-Yassky, MD, PhD, the new Center will be fully integrated within the state-of-the art Laboratory for Inflammatory Skin Diseases, and will fall under the umbrella of the Kimberly and Eric J. Waldman Department of Dermatology at Mount Sinai.

• share
• favorite_border

Mount Sinai scientists have developed a new technology allowing them to link specific genes to complex tumor characteristics at a scale and resolution not previously possible. The results could lead to new approaches for targeting anti-cancer drugs.

• share
• favorite_border

Researchers say some low-income families spend nearly 20 percent of annual income on medical costs during the year of pregnancy and birthing

• share
• favorite_border

In 2010, scientists discovered that African Americans who are born with certain variants of a gene called apolipoprotein L1 (APOL1) have a higher-than-average risk for experiencing chronic kidney disease (CKD). Now, in a new study of African Americans with hypertension, researchers at the Icahn School of Medicine at Mount Sinai find that a community-based approach to reporting APOL1 genetic test results back to individuals may have beneficial effects.

• share
• favorite_border

Findings suggest this region as a promising treatment target

• share
• favorite_border

Study shows better outcomes and fewer complications compared to mechanical or biological aortic valve replacement

• share
• favorite_border

The Icahn School of Medicine at Mount Sinai has been awarded a three-year, $2.1 million Health Workforce Resiliency grant from the Health Resources & Services Administration (HRSA) to develop a new training initiative that will promote well-being, enhance resilience, and aim to reduce the burden of mental health conditions, substance abuse, and suicidal ideation among the health professional workforce.

• share
• favorite_border

Mount Sinai researchers conducting clinical trials of a drug targeting a cancer gene found that it increased metastatic cancer patients’ survival and was able to work within the brain, according to a study published in Clinical Cancer Research in February.

• share
• favorite_border

The Dubin Breast Center of The Tisch Cancer Institute at Mount Sinai, a National Cancer Institute-designated cancer center, raised over $2.5 million during its 11th annual online benefit at the end of 2021.

• share
• favorite_border

Researchers from the Icahn School of Medicine at Mount Sinai have found that nirmatrelvir, molnupiravir, and remdesivir—COVID-19 antiviral therapeutics that have been approved for emergency use by the U.S. Food and Drug Administration—maintain their in vitro antiviral activity against all SARS-CoV-2 variants of concern, including Omicron.

• share
• favorite_border

The Tisch Cancer Institute (TCI) at Mount Sinai and the Samuel Waxman Cancer Research Foundation (SWCRF) are launching a unique research program that will fund collaborations between TCI physician-scientists and colleagues from other established cancer research institutions to address the rising rates of cancer due to aging around the world.

• share
• favorite_border

Cardiologists emphasize importance of exercise, nutrition, mental health to prevent heart disease during COVID-19 pandemic